Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$5.60
+1.6%
$4.49
$2.25
$7.99
$142.46M0.53225,808 shs220,934 shs
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
$0.76
-15.6%
$0.36
$0.13
$1.00
$20.34M0.28164,235 shs266,520 shs
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
$0.54
+1.9%
$0.50
$0.26
$1.14
$18.93M1.5832,532 shs7,504 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
+13.14%+13.14%+17.74%+26.38%-8.47%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
+9.88%+114.98%+173.84%+294.48%+28.70%
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
-2.75%+13.98%+6.43%+2.71%-53.10%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
2.7823 of 5 stars
3.52.00.00.02.24.20.6
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/AN/AN/AN/AN/A
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
0.9244 of 5 stars
2.03.00.00.02.61.70.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
3.00
Buy$18.50230.36% Upside
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/A
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
N/AN/A$3.80603.70% Upside

Current Analyst Ratings

Latest SSKN, GCTK, and DCTH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/27/2024
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$18.00 ➝ $20.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$2.07M68.82N/AN/A$0.72 per share7.78
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/A$0.15 per shareN/A
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
$33.36M0.57N/AN/A$0.37 per share1.46

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-$47.68M-$2.97N/AN/AN/A-2,308.86%-563.60%-111.13%5/27/2024 (Estimated)
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
-$7.10M-$0.37N/AN/AN/A-172.38%-127.42%5/10/2024 (Estimated)
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
-$10.83M-$0.31N/AN/AN/A-32.47%-52.50%-17.66%5/20/2024 (Estimated)

Latest SSKN, GCTK, and DCTH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/28/2024Q4 2023
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/A-$0.10-$0.10-$0.10N/AN/A
3/27/2024Q4 2023
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
N/A-$0.04-$0.04$0.03N/A$8.69 million
3/26/2024Q4 23
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-$0.67-$0.48+$0.19-$0.48$0.48 million$0.54 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/AN/AN/AN/AN/A
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
N/AN/AN/AN/AN/A
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/A
2.26
2.06
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
0.06
3.22
3.22
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
1.19
1.28
1.06

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
61.12%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
10.92%
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
32.43%

Insider Ownership

CompanyInsider Ownership
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
17.94%
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
17.70%
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
40.43%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
7625.44 million20.88 millionOptionable
GlucoTrack, Inc. stock logo
GCTK
GlucoTrack
626.76 million22.02 millionNot Optionable
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
9935.06 million20.89 millionNot Optionable

SSKN, GCTK, and DCTH Headlines

SourceHeadline
STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024
globenewswire.com - April 23 at 8:30 AM
STRATA Skin Sciences (NASDAQ:SSKN) Share Price Crosses Above 200 Day Moving Average of $0.52STRATA Skin Sciences (NASDAQ:SSKN) Share Price Crosses Above 200 Day Moving Average of $0.52
americanbankingnews.com - April 23 at 3:20 AM
STRATA Skin Sciences (SSKN) Price Target Increased by 32.61% to 3.11STRATA Skin Sciences (SSKN) Price Target Increased by 32.61% to 3.11
msn.com - April 18 at 12:46 AM
STRATA Skin Sciences (NASDAQ:SSKN) Share Price Passes Above Two Hundred Day Moving Average of $0.52STRATA Skin Sciences (NASDAQ:SSKN) Share Price Passes Above Two Hundred Day Moving Average of $0.52
americanbankingnews.com - April 13 at 2:40 AM
STRATA Skin Sciences Bolsters International Presence with Renewed Distribution Agreements in AsiaSTRATA Skin Sciences Bolsters International Presence with Renewed Distribution Agreements in Asia
msn.com - April 10 at 7:44 PM
STRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and JapanSTRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan
finanznachrichten.de - April 9 at 2:16 PM
STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and JapanSTRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan
globenewswire.com - April 9 at 8:30 AM
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q4 2023 Earnings Call TranscriptSTRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q4 2023 Earnings Call Transcript
finance.yahoo.com - April 1 at 7:34 PM
STRATA Skin Sciences Unveils 2023 Financial Results: A Look into an Evolving Business ModelSTRATA Skin Sciences Unveils 2023 Financial Results: A Look into an Evolving Business Model
msn.com - March 31 at 6:32 PM
STRATA Skin Sciences, Inc.: STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 EarningsSTRATA Skin Sciences, Inc.: STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings
finanznachrichten.de - March 29 at 3:08 PM
Earnings Preview For Strata Skin SciencesEarnings Preview For Strata Skin Sciences
benzinga.com - March 28 at 10:35 PM
Q4 2023 STRATA Skin Sciences Inc Earnings CallQ4 2023 STRATA Skin Sciences Inc Earnings Call
finance.yahoo.com - March 28 at 8:26 AM
Recap: Strata Skin Sciences Q4 EarningsRecap: Strata Skin Sciences Q4 Earnings
benzinga.com - March 27 at 5:25 PM
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 EarningsSTRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings
globenewswire.com - March 27 at 4:01 PM
STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
globenewswire.com - March 13 at 8:00 AM
Spearheading Change in Dermatology: STRATA Pushes for Expanded Insurance Coverage of Vital Skin TreatmentsSpearheading Change in Dermatology: STRATA Pushes for Expanded Insurance Coverage of Vital Skin Treatments
msn.com - March 11 at 6:59 PM
STRATA Skin Sciences Announces Initiative to Expand Treatment CoverageSTRATA Skin Sciences Announces Initiative to Expand Treatment Coverage
globenewswire.com - March 7 at 8:00 AM
SSKN STRATA Skin Sciences, Inc.SSKN STRATA Skin Sciences, Inc.
seekingalpha.com - March 3 at 12:43 PM
STRATA Skin Sciences Successfully Amends Credit Agreement, Bolstering Strategic InitiativesSTRATA Skin Sciences Successfully Amends Credit Agreement, Bolstering Strategic Initiatives
msn.com - February 29 at 2:54 PM
STRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap FinancialSTRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap Financial
finanznachrichten.de - February 27 at 10:35 AM
STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap FinancialSTRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap Financial
globenewswire.com - February 26 at 4:01 PM
Strata Skin Sciences Inc SSKNStrata Skin Sciences Inc SSKN
morningstar.com - February 22 at 7:35 AM
STRATA Skin Sciences, Inc. (NASDAQ:SSKN): Are Analysts Optimistic?STRATA Skin Sciences, Inc. (NASDAQ:SSKN): Are Analysts Optimistic?
finance.yahoo.com - January 11 at 10:36 AM
STRATA Skin Sciences to Present Poster Showcasing Safety and Efficacy of TheraClear®X for Acne at Maui Derm 2024 ConferenceSTRATA Skin Sciences to Present Poster Showcasing Safety and Efficacy of TheraClear®X for Acne at Maui Derm 2024 Conference
finance.yahoo.com - January 8 at 8:23 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Delcath Systems logo

Delcath Systems

NASDAQ:DCTH
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.
GlucoTrack logo

GlucoTrack

NASDAQ:GCTK
GlucoTrack, Inc., a medical device company, focuses on designing, developing, and commercializing non-invasive glucose monitoring devices for use by people with diabetes in the United States. It develops GlucoTrack, a non-invasive blood glucose monitor that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
STRATA Skin Sciences logo

STRATA Skin Sciences

NASDAQ:SSKN
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.